DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Boku N. et al.
Phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer.
J Clin Oncol 1999; 17: 319-323
We do not assume any responsibility for the contents of the web pages of other providers.